Repros Therapeutics, Inc. (RPRX) Posts Narrower than Expected Q3 Loss
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/8/2026
- S&P 500, Nasdaq end lower as crude prices jump, chip stocks weigh
- Oil rises 4% on revived Middle East worries, Hurricane Isaias supply disruption
- Chipotle, Starbucks shares volatile after report of potential takeover
- Why Citi says the Fed could be setting up for a dovish surprise
- Alphabet shares rise as Google pushes Gemini deeper into enterprise AI
Tweet
Share
E-mailGet Alerts RPRX Hot Sheet
Price: $56.21 -0.97%
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
PKE, BYRN, HELE, More
Financial Fact:
Research and development: 3.18M
Today's EPS Names:
PKE, BYRN, HELE, More
Join SI Premium – FREE
Repros Therapeutics, Inc. (NASDAQ: RPRX) reported Q3 loss of ($0.32), $0.03 better than the analyst estimate of ($0.35).
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Royalty Pharma (RPRX) PT Raised to $67 at Morgan Stanley
- Lamb Weston (LW) Tops Q1 EPS by 15c ; Offers Guidance
- Applied Digital (APLD) Tops Q1 EPS by 26c, Beats on Revenue
Create E-mail Alert Related Categories
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
